Literature DB >> 24529342

A sensitive LC-MS/MS method for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells.

Xiaowei Tu1, Youming Lu1, Dafang Zhong1, Yifan Zhang1, Xiaoyan Chen2.   

Abstract

Clofarabine triphosphate is an intracellular active metabolite of clofarabine. In the present study, we developed and validated a rapid, sensitive, and selective liquid chromatography-tandem mass spectrometry method (LC-MS/MS) for quantifying clofarabine triphosphate concentrations in human peripheral blood mononuclear cells (PBMCs). PBMCs were isolated from blood using the Ficoll gradient centrifugation method. Chromatographic separation was performed on a CN column using an isocratic mobile phase comprising acetonitrile/5mM ammonium acetate with 0.001% ammonium hydroxide (20/80, v/v) at a flow rate of 0.60 mL/min. Detection was carried out by MS/MS in the multiple reaction monitoring mode using a negative electrospray ionization interface. The method was validated in concentration ranges of 1.25-100 ng/10(7) cells with acceptable accuracy and precision using 50 μL of cell extract. Clofarabine triphosphate was stable in a series of stability studies with bench-top, auto-sampler, and repeated freeze-thaw cycles. The validated method was successfully used to measure the concentrations of clofarabine triphosphate in PBMCs from cancer patients treated with clofarabine.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clofarabine; Clofarabine triphosphate; Liquid chromatography–tandem mass spectrometry; Peripheral blood mononuclear cells

Mesh:

Substances:

Year:  2014        PMID: 24529342     DOI: 10.1016/j.jchromb.2014.01.021

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC-MS/MS.

Authors:  Wenjuan Hu; Lu Chang; Changqiang Ke; Yuanchao Xie; Jingshan Shen; Bo Tan; Jia Liu
Journal:  J Pharm Biomed Anal       Date:  2020-11-30       Impact factor: 3.935

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.